1. Home
  2. VRNA
  3. VRNA News

Latest Verona Pharma plc (VRNA) News on May 16, 2025

Why Verona Pharma plc (VRNA) is Among the Best Performing Healthcare Stocks to Buy Now
VRNA

Insider Monkey

3 days ago

Why Verona Pharma plc (VRNA) is Among the Best Performing Healthcare Stocks to Buy Now

What Makes Verona Pharma plc (VRNA) a Good Investment?
VRNA

Insider Monkey

8 days ago

What Makes Verona Pharma plc (VRNA) a Good Investment?

IBD Stock Of The Day Verona Pharma Tests Buy Point After Earnings Breakout
VRNA

Investor's Business Daily

9 days ago

IBD Stock Of The Day Verona Pharma Tests Buy Point After Earnings Breakout

Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025
VRNA

GlobeNewswire

10 days ago

Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025

VRNA

MT Newswires

14 days ago

Verona Pharma Insider Sold Shares Worth $811,433, According to a Recent SEC Filing

Why Verona Pharma plc (VRNA) Soared on Tuesday
VRNA

Insider Monkey

15 days ago

Why Verona Pharma plc (VRNA) Soared on Tuesday

Analysts Are Betting On Verona Pharma plc (NASDAQ:VRNA) With A Big Upgrade This Week
VRNA

Simply Wall St.

16 days ago

Analysts Are Betting On Verona Pharma plc (NASDAQ:VRNA) With A Big Upgrade This Week

Verona Pharma PLC (VRNA) Q1 2025 Earnings Call Highlights: Strong Ohtuvayre Sales Propel ...
VRNA

GuruFocus.com

16 days ago

Verona Pharma PLC (VRNA) Q1 2025 Earnings Call Highlights: Strong Ohtuvayre Sales Propel ...

VRNA

MT Newswires

17 days ago

Truist Securities Adjusts Verona Pharma Price Target to $100 From $76, Maintains Buy Rating

VRNA

MT Newswires

17 days ago

Top Midday Gainers

VRNA

MT Newswires

17 days ago

Top Premarket Gainers

VRNA

MT Newswires

17 days ago

Verona Pharma Q1 Loss Narrows, Revenue Increases -- Shares Rise Pre-Bell

Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update
VRNA

GlobeNewswire

17 days ago

Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

Verona Pharma PLC (VRNA) Q1 2025: Everything You Need To Know Ahead Of Earnings
VRNA

GuruFocus.com

17 days ago

Verona Pharma PLC (VRNA) Q1 2025: Everything You Need To Know Ahead Of Earnings

Verona Pharma plc (VRNA): Among the Best Multibagger Stocks to Buy According to Billionaires
VRNA

Insider Monkey

22 days ago

Verona Pharma plc (VRNA): Among the Best Multibagger Stocks to Buy According to Billionaires

VRNA

MT Newswires

25 days ago

Cantor Fitzgerald Initiates Verona Pharma at Overweight

Ritedose to double single-vial packaging capabilities with seventh Syntegon line
VRNA

Packaging Gateway

a month ago

Ritedose to double single-vial packaging capabilities with seventh Syntegon line

Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update
VRNA

GlobeNewswire

a month ago

Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update

VRNA

MT Newswires

2 months ago

Verona Pharma Re-Works Loan Packages, Boosting Borrowing Capacity, Lowering Expense

Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS
VRNA

GlobeNewswire

2 months ago

Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS

Jim Cramer Advises Caution on Verona Pharma (VRNA): “Risky – Sell Half and Let the Rest Ride”
VRNA

Insider Monkey

2 months ago

Jim Cramer Advises Caution on Verona Pharma (VRNA): “Risky – Sell Half and Let the Rest Ride”

Is Verona Pharma plc (VRNA) the Best Performing Growth Stock in 2025?
VRNA

Insider Monkey

2 months ago

Is Verona Pharma plc (VRNA) the Best Performing Growth Stock in 2025?

Verona Pharma plc (VRNA): A Bull Case Theory
VRNA

Insider Monkey

2 months ago

Verona Pharma plc (VRNA): A Bull Case Theory

Beat the Market the Zacks Way: Verona, Visa, Starbucks in Focus
VRNA

Zacks

2 months ago

Beat the Market the Zacks Way: Verona, Visa, Starbucks in Focus

Earnings Beat: Verona Pharma plc (NASDAQ:VRNA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
VRNA

Simply Wall St.

2 months ago

Earnings Beat: Verona Pharma plc (NASDAQ:VRNA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Verona Pharma PLC (VRNA) Q4 2024 Earnings Call Highlights: Strong Launch of Ohtuvayre Amid ...
VRNA

GuruFocus.com

3 months ago

Verona Pharma PLC (VRNA) Q4 2024 Earnings Call Highlights: Strong Launch of Ohtuvayre Amid ...

VRNA

MT Newswires

3 months ago

Truist Securities Adjusts Verona Pharma Price Target to $76 From $57, Maintains Buy Rating

VRNA

MT Newswires

3 months ago

Verona Pharma Q4 Loss Widens

Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
VRNA

GlobeNewswire

3 months ago

Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Earnings To Watch: Verona Pharma PLC (VRNA) Reports Q4 2024 Result
VRNA

GuruFocus.com

3 months ago

Earnings To Watch: Verona Pharma PLC (VRNA) Reports Q4 2024 Result

Verona Pharma plc (VRNA): The Best Performing Pharma Stock So Far in 2025?
VRNA

Insider Monkey

3 months ago

Verona Pharma plc (VRNA): The Best Performing Pharma Stock So Far in 2025?

Verona Pharma Announces March 2025 Investor Conference Participation
VRNA

GlobeNewswire

3 months ago

Verona Pharma Announces March 2025 Investor Conference Participation

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update
VRNA

GlobeNewswire

3 months ago

Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing'
VRNA

Zacks

3 months ago

What Makes Verona Pharma (VRNA) a Good Fit for 'Trend Investing'

Here's Why 'Trend' Investors Would Love Betting on Verona Pharma (VRNA)
VRNA

Zacks

4 months ago

Here's Why 'Trend' Investors Would Love Betting on Verona Pharma (VRNA)

Is Verona Pharma (VRNA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?
VRNA

Insider Monkey

4 months ago

Is Verona Pharma (VRNA) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week
VRNA

Investor's Business Daily

4 months ago

Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week

Wall Street Analysts See a 30.65% Upside in Verona Pharma (VRNA): Can the Stock Really Move This High?
VRNA

Zacks

4 months ago

Wall Street Analysts See a 30.65% Upside in Verona Pharma (VRNA): Can the Stock Really Move This High?

Verona Pharma (VRNA) Upgraded to Buy: What Does It Mean for the Stock?
VRNA

Zacks

4 months ago

Verona Pharma (VRNA) Upgraded to Buy: What Does It Mean for the Stock?

VRNA

MT Newswires

4 months ago

Roth Initiates Verona Pharma at Buy

Analysts Expect Breakeven For Verona Pharma plc (NASDAQ:VRNA) Before Long
VRNA

Simply Wall St.

4 months ago

Analysts Expect Breakeven For Verona Pharma plc (NASDAQ:VRNA) Before Long

Verona Pharma (VRNA) is on the Move, Here's Why the Trend Could be Sustainable
VRNA

Zacks

4 months ago

Verona Pharma (VRNA) is on the Move, Here's Why the Trend Could be Sustainable

VRNA

MT Newswires

4 months ago

Verona Pharma to Report $36 Million in Q4 Net Product Revenue

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights
VRNA

GlobeNewswire

4 months ago

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

VRNA

MT Newswires

6 months ago

Verona Pharma Insider Sold Shares Worth $1,176,360, According to a Recent SEC Filing

Verona Pharma Announces December 2024 Investor Conference Participation
VRNA

GlobeNewswire

6 months ago

Verona Pharma Announces December 2024 Investor Conference Participation

VRNA

MT Newswires

6 months ago

Verona Pharma Insider Sold Shares Worth $568,387, According to a Recent SEC Filing

VRNA

MT Newswires

6 months ago

Verona Pharma Insider Sold Shares Worth $618,658, According to a Recent SEC Filing

Verona Pharma (NASDAQ:VRNA) shareholder returns have been incredible, earning 724% in 5 years
VRNA

Simply Wall St.

6 months ago

Verona Pharma (NASDAQ:VRNA) shareholder returns have been incredible, earning 724% in 5 years

Verona Pharma PLC (VRNA) Q3 2024 Earnings Call Highlights: Strong Ohtuvayre Launch Amid Rising Costs
VRNA

GuruFocus.com

6 months ago

Verona Pharma PLC (VRNA) Q3 2024 Earnings Call Highlights: Strong Ohtuvayre Launch Amid Rising Costs

Verona Pharma to Present at Jefferies London Healthcare Conference
VRNA

GlobeNewswire

6 months ago

Verona Pharma to Present at Jefferies London Healthcare Conference

VRNA

MT Newswires

6 months ago

Verona Pharma's Q3 Loss Widens

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
VRNA

GlobeNewswire

6 months ago

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma PLC (VRNA) Q3 2024 Earnings Report Preview: What To Expect
VRNA

GuruFocus.com

6 months ago

Verona Pharma PLC (VRNA) Q3 2024 Earnings Report Preview: What To Expect

Recent Price Trend in Verona Pharma (VRNA) is Your Friend, Here's Why
VRNA

Zacks

7 months ago

Recent Price Trend in Verona Pharma (VRNA) is Your Friend, Here's Why

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma
VRNA

Zacks

7 months ago

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright
VRNA

Zacks

7 months ago

5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

VRNA

MT Newswires

7 months ago

Verona Pharma Insider Sold Shares Worth $2,253,237, According to a Recent SEC Filing

VRNA

MT Newswires

7 months ago

Verona Pharma Insider Sold Shares Worth $2,303,773, According to a Recent SEC Filing

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update
VRNA

GlobeNewswire

7 months ago

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update

Wall Street Analysts Think Verona Pharma (VRNA) Could Surge 25.25%: Read This Before Placing a Bet
VRNA

Zacks

7 months ago

Wall Street Analysts Think Verona Pharma (VRNA) Could Surge 25.25%: Read This Before Placing a Bet

Verona Pharma (VRNA) Is a Great Choice for 'Trend' Investors, Here's Why
VRNA

Zacks

7 months ago

Verona Pharma (VRNA) Is a Great Choice for 'Trend' Investors, Here's Why

VRNA

MT Newswires

7 months ago

Wells Fargo Initiates Verona Pharma at Overweight With $50 Price Target

Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024
VRNA

GlobeNewswire

8 months ago

Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024

Insider Sale: CFO Mark Hahn Sells 600,000 Shares of Verona Pharma PLC (VRNA)
VRNA

GuruFocus.com

8 months ago

Insider Sale: CFO Mark Hahn Sells 600,000 Shares of Verona Pharma PLC (VRNA)

Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares
VRNA

GuruFocus.com

8 months ago

Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares

Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024
VRNA

GlobeNewswire

8 months ago

Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024

Insider Sale: CFO Mark Hahn Sells 400,000 Shares of Verona Pharma PLC (VRNA)
VRNA

GuruFocus.com

9 months ago

Insider Sale: CFO Mark Hahn Sells 400,000 Shares of Verona Pharma PLC (VRNA)

Is Verona Pharma plc (VRNA) a Good Addition to Your Portfolio Now?
VRNA

Insider Monkey

9 months ago

Is Verona Pharma plc (VRNA) a Good Addition to Your Portfolio Now?

VRNA

MT Newswires

9 months ago

Verona Pharma Q2 Net Loss Widens

Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
VRNA

GlobeNewswire

9 months ago

Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma plc's (NASDAQ:VRNA) Path To Profitability
VRNA

Simply Wall St.

9 months ago

Verona Pharma plc's (NASDAQ:VRNA) Path To Profitability

Verona Pharma to Present at 44th Annual Canaccord Growth Conference
VRNA

GlobeNewswire

10 months ago

Verona Pharma to Present at 44th Annual Canaccord Growth Conference

Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update
VRNA

GlobeNewswire

10 months ago

Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update

VRNA

MT Newswires

10 months ago

Canaccord Genuity Raises Verona Pharma's Price Target to $37 From $35, Maintains Buy Rating

Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why
VRNA

Zacks

10 months ago

Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why

VRNA

MT Newswires

a year ago

Truist Securities Raises Price Target on Verona Pharma to $38 From $32, Maintains Buy Rating

Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy
VRNA

Pharmaceutical Technology

a year ago

Verona scores FDA approval for Ohtuvayre as COPD maintenance therapy

First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product
VRNA

Benzinga

a year ago

First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product

FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market
VRNA

Pharmaceutical Technology

a year ago

FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market

VRNA

MT Newswires

a year ago

HC Wainwright Adjusts Price Target on Verona Pharma to $36 From $32, Maintains Buy Rating

VRNA

MT Newswires

a year ago

Update: Verona Pharma Gets FDA Nod for Pulmonary Disease Treatment; Shares Jump Premarket

VRNA

MT Newswires

a year ago

Verona Pharma Gets US FDA Approval for Ohtuvayre in Chronic Obstructive Pulmonary Disease

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)
VRNA

GlobeNewswire

a year ago

Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine)

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
VRNA

Investor's Business Daily

a year ago

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

FDA panel votes to recommend Eli Lilly's Alzheimer's drug
VRNA

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

VRNA

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit
VRNA

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

VRNA

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
VRNA

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
VRNA

GlobeNewswire

a year ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas
VRNA

Business Wire

a year ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research
VRNA

GlobeNewswire

a year ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024
VRNA

Pharmaceutical Technology

a year ago

Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024

VRNA

GuruFocus.com

a year ago

Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview

Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript
VRNA

Insider Monkey

a year ago

Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript

VRNA

MT Newswires

a year ago

Verona Pharma Signs Financing Agreements for Up to $650 Million

VRNA

MT Newswires

a year ago

Verona Pharma Shares Decline After Q1 Loss Widens

Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
VRNA

GlobeNewswire

a year ago

Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
VRNA

GlobeNewswire

a year ago

Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS

Share on Social Networks: